The profile of poor ICS adherence in uncontrolled moderate to severe asthma. Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020
Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 72s Year: 2007
Higher resource use and lower asthma-related QOL in patients with severe or difficult-to-treat asthma Source: Eur Respir J 2003; 22: Suppl. 45, 296s Year: 2003
Tiotropium improved asthma symptoms and increased time to first exacerbation in patients with moderate-to-severe asthma. Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
Predictors of response to therapy with omalizumab in patients with severe allergic asthma–a real life study Source: International Congress 2017 – Monitoring asthma control Year: 2017
Dyspnea sensation and health-related quality predict exacerbations, hospitalizations and mortality in patients with chronic respiratory failure receiving long-term oxygen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 519s Year: 2006
Dysfunctional breathing in patients with severe asthma is associated with poor asthma control and low quality of life. Source: International Congress 2017 – Techniques to treat asthma Year: 2017
Asthma patients adjust their maintenance treatment late in response to worsening asthma symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 7s Year: 2005
Under reporting acute exacerbation in patient with COPD: incidence and predictors? Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013
Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015
Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 267s Year: 2001
Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials Source: Eur Respir J, 53 (5) 1900599; 10.1183/13993003.00599-2019 Year: 2019
Can poor compliance be a predictor of asthma exacerbations severity in Ukrainian patients? Source: Eur Respir J 2006; 28: Suppl. 50, 687s Year: 2006
Poor quality of life is associated with frequent exacerbations in moderate-to-severe COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 190s Year: 2001
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005